Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Matthew J. Knight, Natalie T. Mills & Bernhard T. Baune. (2019) Contemporary methods of improving cognitive dysfunction in clinical depression. Expert Review of Neurotherapeutics 19:5, pages 431-443.
Read now
Read now
Hsiao-Jou Cortina Chen, Jereme G. Spiers, Conrad Sernia, Stephen T. Anderson & Nickolas A. Lavidis. (2014) Reactive nitrogen species contribute to the rapid onset of redox changes induced by acute immobilization stress in rats. Stress 17:6, pages 520-527.
Read now
Read now
Miao Hu & Brian Tomlinson. (2013) Current Perspectives on rosuvastatin. Integrated Blood Pressure Control 6, pages 15-25.
Read now
Read now
Yong-Hyun Kim, Seong-Mi Park, Mina Kim, Seong Hwan Kim, Sang-Yeob Lim, Jeong-Cheon Ahn, Woo-Hyuk Song & Wan-Joo Shim. (2012) Cardioprotective effects of rosuvastatin and carvedilol on delayed cardiotoxicity of doxorubicin in rats. Toxicology Mechanisms and Methods 22:6, pages 488-498.
Read now
Read now
Xiu-Di Pan, Zhao-Hua Zeng, Li-Ying Liang, Jian-Dong Luo, Ai-Yi Xiao, Qing Lai, Yan-Hang Wen, Dong-Feng Lu, Wei Wang, Zhao-Chu He & Wen-Kai He. (2011) The Effects of Simvastatin on Left Ventricular Hypertrophy and Left Ventricular Function in Patients with Essential Hypertension. Clinical and Experimental Hypertension 33:8, pages 558-564.
Read now
Read now
Leonardo Calza. (2009) Long-term use of rosuvastatin: a critical risk benefit appraisal and comparison with other antihyperlipidemics. Drug, Healthcare and Patient Safety 1, pages 25-33.
Read now
Read now
Articles from other publishers (33)
Luc Rochette, Loubna Mazini, Gabriel Malka, Marianne Zeller, Yves Cottin & Catherine Vergely. (2020) The Crosstalk of Adipose-Derived Stem Cells (ADSC), Oxidative Stress, and Inflammation in Protective and Adaptive Responses. International Journal of Molecular Sciences 21:23, pages 9262.
Crossref
Crossref
Michael Berk, Mohammadreza Mohebbi, Olivia M. Dean, Sue M. Cotton, Andrew M. Chanen, Seetal Dodd, Aswin Ratheesh, G. Paul Amminger, Mark Phelan, Amber Weller, Andrew Mackinnon, Francesco Giorlando, Shelley Baird, Lisa Incerti, Rachel E. Brodie, Natalie O. Ferguson, Simon Rice, Miriam R. Schäfer, Edward Mullen, Sarah Hetrick, Melissa Kerr, Susy M. Harrigan, Amelia L. Quinn, Catherine Mazza, Patrick McGorry & Christopher G. Davey. (2020) Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin. BMC Medicine 18:1.
Crossref
Crossref
Ibrahim Elsayed, Rania Moataz El-Dahmy, Soad Z. El-Emam, Ahmed Hassen Elshafeey, Nabaweya Abdelaziz Abd El Gawad & Omaima Naim El-Gazayerly. (2020) Response surface optimization of biocompatible elastic nanovesicles loaded with rosuvastatin calcium: enhanced bioavailability and anticancer efficacy. Drug Delivery and Translational Research 10:5, pages 1459-1475.
Crossref
Crossref
Paul Denver, Heather D’Adamo, Shuxin Hu, Xiaohong Zuo, Cansheng Zhu, Chihiro Okuma, Peter Kim, Daniel Castro, Mychica R. Jones, Carmen Leal, Marisa Mekkittikul, Elham Ghadishah, Bruce Teter, Harry V. Vinters, Gregory Michael Cole & Sally A. Frautschy. (2019) A Novel Model of Mixed Vascular Dementia Incorporating Hypertension in a Rat Model of Alzheimer’s Disease. Frontiers in Physiology 10.
Crossref
Crossref
Eduard Dumitrescu, Kenneth N. Wallace & Silvana Andreescu. (2018) Real time electrochemical investigation of the release, distribution and modulation of nitric oxide in the intestine of individual zebrafish embryos. Nitric Oxide 74, pages 32-38.
Crossref
Crossref
Amelia L. Quinn, Olivia M. Dean, Christopher G. Davey, Melissa Kerr, Susy M. Harrigan, Sue M. Cotton, Andrew M. Chanen, Seetal Dodd, Aswin Ratheesh, G. Paul Amminger, Mark Phelan, Amber Williams, Andrew Mackinnon, Francesco Giorlando, Shelley Baird, Simon Rice, Melissa O'Shea, Miriam R. Schäfer, Edward Mullen, Sarah Hetrick, Patrick McGorry & Michael Berk. (2018) Youth Depression Alleviation-Augmentation with an anti-inflammatory agent (YoDA-A): protocol and rationale for a placebo-controlled randomized trial of rosuvastatin and aspirin. Early Intervention in Psychiatry 12:1, pages 45-54.
Crossref
Crossref
You‐Lin Tain & Chien‐Ning Hsu. (2017) Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA). Toxins 9:3, pages 92.
Crossref
Crossref
H.-Y. Bai, M. Mogi, H. Nakaoka, H. Kan-no, K. Tsukuda, X.-L. Wang, B.-S. Shan, M. Kukida, T. Yamauchi, A. Higaki, L.-J. Min, J. Iwanami & M. Horiuchi. (2016) Synergistic Inhibitory Effect of Rosuvastatin and Angiotensin II Type 2 Receptor Agonist on Vascular Remodeling. Journal of Pharmacology and Experimental Therapeutics 358:2, pages 352-358.
Crossref
Crossref
Jie Deng, Guijun Wu, Chen Yang, Yi Li, Quanmin Jing & Yaling Han. (2015) Rosuvastatin attenuates contrast-induced nephropathy through modulation of nitric oxide, inflammatory responses, oxidative stress and apoptosis in diabetic male rats. Journal of Translational Medicine 13:1.
Crossref
Crossref
Saskia Brinkmann, Elisabeth Wörner, Nikki Buijs, Milan Richir, Luc Cynober, Paul van Leeuwen & Rémy Couderc. (2015) The Arginine/ADMA Ratio Is Related to the Prevention of Atherosclerotic Plaques in Hypercholesterolemic Rabbits When Giving a Combined Therapy with Atorvastatine and Arginine. International Journal of Molecular Sciences 16:12, pages 12230-12242.
Crossref
Crossref
Luc Rochette, Aurélie Gudjoncik, Charles Guenancia, Marianne Zeller, Yves Cottin & Catherine Vergely. (2015) The iron-regulatory hormone hepcidin: A possible therapeutic target?. Pharmacology & Therapeutics 146, pages 35-52.
Crossref
Crossref
Luc Rochette, Marianne Zeller, Yves Cottin & Catherine Vergely. (2014) Diabetes, oxidative stress and therapeutic strategies. Biochimica et Biophysica Acta (BBA) - General Subjects 1840:9, pages 2709-2729.
Crossref
Crossref
Anthony O. Ahmed & Ishrat A. Bhat. (2014) Psychopharmacological Treatment of Neurocognitive Deficits in People with Schizophrenia: A Review of Old and New Targets. CNS Drugs 28:4, pages 301-318.
Crossref
Crossref
Marios MargaritisKeith M. ChannonCharalambos Antoniades. (2014) Statins as Regulators of Redox State in the Vascular Endothelium: Beyond Lipid Lowering. Antioxidants & Redox Signaling 20:8, pages 1198-1215.
Crossref
Crossref
D. Bloemberg, E. McDonald, D. Dulay & J. Quadrilatero. (2014) Autophagy is altered in skeletal and cardiac muscle of spontaneously hypertensive rats. Acta Physiologica 210:2, pages 381-391.
Crossref
Crossref
Yuanji Ma, Zhaoyang Chen, Yunzeng Zou & Junbo Ge. (2014) Atorvastatin Represses the Angiotensin 2-Induced Oxidative Stress and Inflammatory Response in Dendritic Cells via the PI3K/Akt/Nrf 2 Pathway. Oxidative Medicine and Cellular Longevity 2014, pages 1-10.
Crossref
Crossref
Luc Rochette & Catherine Vergely. 2014. Systems Biology of Free Radicals and Antioxidants. Systems Biology of Free Radicals and Antioxidants
3437
3466
.
Julie Lorin, Marianne Zeller, Jean-Claude Guilland, Yves Cottin, Catherine Vergely & Luc Rochette. (2014) Arginine and nitric oxide synthase: Regulatory mechanisms and cardiovascular aspects. Molecular Nutrition & Food Research 58:1, pages 101-116.
Crossref
Crossref
Luc Rochette, Julie Lorin, Marianne Zeller, Jean-Claude Guilland, Luc Lorgis, Yves Cottin & Catherine Vergely. (2013) Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: Possible therapeutic targets?. Pharmacology & Therapeutics 140:3, pages 239-257.
Crossref
Crossref
S Moylan, M Maes, N R Wray & M Berk. (2012) The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Molecular Psychiatry 18:5, pages 595-606.
Crossref
Crossref
Seetal Dodd, Michael Maes, George Anderson, Olivia M. Dean, Steven Moylan & Michael Berk. (2013) Putative neuroprotective agents in neuropsychiatric disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 42, pages 135-145.
Crossref
Crossref
Luc Rochette, Yves Cottin, Marianne Zeller & Catherine Vergely. (2013) Carbon monoxide: Mechanisms of action and potential clinical implications. Pharmacology & Therapeutics 137:2, pages 133-152.
Crossref
Crossref
Sonam Kathuria, Nanjaian Mahadevan & Pitchai Balakumar. (2012) Possible involvement of PPARγ-associated eNOS signaling activation in rosuvastatin-mediated prevention of nicotine-induced experimental vascular endothelial abnormalities. Molecular and Cellular Biochemistry 374:1-2, pages 61-72.
Crossref
Crossref
Sébastien Amoureux, Luc Lorgis, Pierre Sicard, Claude Girard, Luc Rochette & Catherine Vergely. (2011) Vascular BDNF expression and oxidative stress during aging and the development of chronic hypertension. Fundamental & Clinical Pharmacology 26:2, pages 227-234.
Crossref
Crossref
Rodrigo Neto-Ferreira, Vinícius Novaes Rocha, Thiago da Silva Torres, Carlos Alberto Mandarim-de-Lacerda & Jorge Jose de Carvalho. (2011) Beneficial effects of rosuvastatin on aortic adverse remodeling in nitric oxide-deficient rats. Experimental and Toxicologic Pathology 63:5, pages 473-478.
Crossref
Crossref
C. Korandji, M. Zeller, J.C. Guilland, B. Collin, B. Lauzier, P. Sicard, L. Duvillard, F. Goirand, D. Moreau, Y. Cottin, L. Rochette & C. Vergely. (2011) Time course of asymmetric dimethylarginine (ADMA) and oxidative stress in fructose-hypertensive rats: A model related to metabolic syndrome. Atherosclerosis 214:2, pages 310-315.
Crossref
Crossref
Anastazia Kei, Moses Elisaf, Elisavet Moutzouri, Stavroula Tsiara & Evangelos Liberopoulos. (2011) Add-on-Statin Extended Release Nicotinic Acid/Laropiprant but Not the Switch to High-Dose Rosuvastatin Lowers Blood Pressure: An Open-Label Randomized Study. International Journal of Hypertension 2011, pages 1-6.
Crossref
Crossref
Mahesh M. Ghaisas, Prasad R. Dandawate, Suyash A. Zawar, Yogesh S. Ahire & Santosh P. Gandhi. (2010) Antioxidant, antinociceptive and anti-inflammatory activities of atorvastatin and rosuvastatin in various experimental models. Inflammopharmacology 18:4, pages 169-177.
Crossref
Crossref
M. A. Gilinsky, T. V. Latysheva & G. M. Petrakova. (2010) Dimethylarginines and Serotonin in the Blood of Spontaneously Hypertensive Rats. Bulletin of Experimental Biology and Medicine 148:6, pages 849-851.
Crossref
Crossref
Harumi Kanno, Masaru Iwai, Shinji Inaba, Izumi Senba, Hirotomo Nakaoka, Hisako Sone, Masaki Mogi & Masatsugu Horiuchi. (2009) Improvement of glucose intolerance by combination of pravastatin and olmesartan in type II diabetic KK-Ay mice. Hypertension Research 32:8, pages 706-711.
Crossref
Crossref
Ana M. BrionesNatalia Rodríguez-CriadoRaquel HernanzAna B. García-RedondoRaul R. Rodrigues-DíezMaría J. AlonsoJesús EgidoMarta Ruiz-OrtegaMercedes Salaices. (2009) Atorvastatin Prevents Angiotensin II–Induced Vascular Remodeling and Oxidative Stress. Hypertension 54:1, pages 142-149.
Crossref
Crossref
Wenhao Cui, Kuniharu Matsuno, Kazumi Iwata, Masakazu Ibi, Masato Katsuyama, Tomoko Kakehi, Mika Sasaki, Kanako Ikami, Kai Zhu & Chihiro Yabe-Nishimura. (2009) NADPH Oxidase Isoforms and Anti-hypertensive Effects of Atorvastatin Demonstrated in Two Animal Models. Journal of Pharmacological Sciences 111:3, pages 260-268.
Crossref
Crossref
Hui-Yun Tsai, Liang-Yi Wu & Lucy Sun Hwang. (2008) Effect of a Proanthocyanidin-Rich Extract from Longan Flower on Markers of Metabolic Syndrome in Fructose-Fed Rats. Journal of Agricultural and Food Chemistry 56:22, pages 11018-11024.
Crossref
Crossref